MASScot does not endorse nor is affiliated with any of the content contained within these links.
- Melanoma Survival Better With Immune Booster
Patients with metastatic melanoma who were treated with ipilimumab, an immune checkpoint blocker, survived 50% longer – a median 17.5 months vs. 12.7 months – if they simultaneously received an immune stimulant, according to a study led by Dana-Farber Cancer Institute scientists.
Source: DDD Mag
- University of Pittsburgh Cancer Institute to open Melanoma Tissue Bank
From autism to prostate cancer, researchers rely on specialized banks of donated human tissue to explore how diseases attack the body and what might stop them.
Source: Trib Live
- Nine weeks of biochemotherapy effective for high-risk melanoma
A 9-week course of multiagent biochemotherapy markedly improved relapse-free survival in patients with high-risk melanoma, compared with the 1-year course of high-dose interferon that has been the unchallenged standard of care for this disease for decades, according to a report published online Oct. 27 in the Journal of Clinical Oncology.
Source: Oncology Practice
- Uveal Melanoma Successfully Treated with Lower Doses of Radiation
Rare as it is, uveal melanoma–or cancer in the eye involving the iris, cilliary body, or choroid–is the most common primary cancer of the eye, according to the National Cancer Institute. Treatment of uveal melanoma is achieved with radiation therapy, although a variety of regimens and techniques have been applied successfully. A new retrospective study performed by researchers at Duke University, “Uveal Melanoma Treated with Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes,” identified 69 Gy of radiation applied at the tumor apex to be sufficient to control tumor growth and enhance distant metastasis-free survival.
Source: Radiation Therapy News
- New study finds school uniform alterations could reduce risk of skin cancer in school children
A new study has found that lowering the hemlines on school uniforms could reduce the risk of skin cancer.
The research, which comes from James Cook University in Queensland, found that increasing the average uniform covering to the knees and elbows could increase sun protection by over 9 per cent.
Source: Daily Mail
- New Pain Free Technology Detects Skin Cancer
Now, there's an easier, pain-free way to check suspicious moles, called MelaFind.
"It really helps us decide which lesions need to be biopsied," said Dr. Philip Bailin, a dermatologist at Cleveland Clinic.
The test takes less than a minute. The scanner transmits 10 different wavelengths of light into the skin and takes an image of the patient's mole. That image is compared to others in a database of more than 10,000 lesions.
Source: ABC 7
No comments:
Post a Comment